MOORE CAPITAL MANAGEMENT, LP
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1448574
NEW YORK, NY
Position in RARE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,291,915
-$1,308,085 QoQ
Shares Held
157,132
-21.4% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Derivatives in RARE
reported options exposure · as of Dec 31, 2025CallValue
$9,275,900
CallShares
403,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MOORE CAPITAL MANAGEMENT, LP holds $51,235,346 across 22 Biotechnology names. RARE ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
197,308 | $5,948,836 | |
| 2 | GMAB |
Genmab A/S
|
211,705 | $5,680,045 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
55,600 | $5,407,100 | |
| 4 | IRON |
Disc Medicine, Inc.
|
57,796 | $3,695,476 | |
| 5 | ATAI |
AtaiBeckley Inc.
|
952,380 | $3,371,425 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
This page
|
157,132 | $3,291,915 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
44,694 | $3,045,002 | |
| 8 | REPL |
Replimune Group, Inc.
|
311,124 | $2,380,098 |
All Filings in RARE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,291,915 | 157,132 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,275,900 | 403,300 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $4,600,000 | 200,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,121,600 | 270,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,272,000 | 200,000 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $10,544,400 | 290,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,690,400 | 240,000 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $2,103,500 | 50,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $10,307,150 | 245,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,609,750 | 245,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $5,555,000 | 100,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $10,069,500 | 245,000 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $4,110,000 | 100,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $8,637,650 | 185,000 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $3,501,750 | 75,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $8,846,700 | 185,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,347,500 | 150,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,843,650 | 105,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,203,000 | 30,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||